Arash Keshavarzi - Venture Fellow and Computational Biologist

Professional Overview

Arash Keshavarzi is a versatile and accomplished professional with expertise in venture capital, computational biology, and machine learning. Combining his technical acumen and entrepreneurial mindset, he currently serves as a Venture Fellow at Mubadala Capital, a leading global investment firm, while also holding positions as a Postdoctoral Researcher in GenAI in BioMed at Stanford University and as a Co-Founder at Lumos Bio.

Experience Summary

Current Roles

Venture Fellow, Mubadala Capital (2024-01-01 to Present)

Evaluates emerging technologies and investment opportunities in the life sciences and biotechnology sectors

Provides strategic insights and recommendations to the investment team to inform portfolio management and growth strategies

Collaborates with portfolio companies to identify and implement innovative solutions to drive business objectives

Postdoctoral Researcher, GenAI in BioMed, Stanford University (2023-08-01 to Present)

Conducts cutting-edge research in the intersection of generative AI and biomedical applications

Develops novel machine learning models and algorithms to accelerate drug discovery and disease modeling

Publishes research findings in peer-reviewed journals and presents at industry conferences

Co-Founder, Lumos Bio (2023-08-01 to Present)

Leads the strategic and technical direction of the startup, which leverages AI and computational biology to develop innovative biotherapeutics

Oversees the design and implementation of the company's core technology platform

Builds and manages a highly skilled team of scientists and engineers to drive product development and commercialization

Career Progression

Postdoctoral Researcher, AI Drug Discovery, University of California, San Francisco (2023-01-01 to 2023-08-01)

Developed novel deep learning models for accelerating small molecule drug discovery

Collaborated with industry partners to apply state-of-the-art AI techniques to enhance drug candidate identification and optimization

Chief Scientific Officer, Nucleus (2022-01-01 to 2022-01-01)

Oversaw the scientific and technical direction of the startup, leading the research and development of its core AI-powered platform

Spearheaded the successful acquisition of Nucleus by a larger life sciences company

Computational Biologist, ML, Labcorp (2021-05-01 to 2021-09-01)

Leveraged machine learning and data analytics to drive insights and improvements in various clinical and diagnostic workflows

Contributed to the development of innovative computational tools and algorithms to enhance the company's service offerings

Academic Background

Arash holds a Ph.D. in Computational Biology from the University of Cambridge, where he specialized in the application of machine learning and artificial intelligence to solve complex problems in the life sciences. He has published his research in prestigious peer-reviewed journals and has been recognized for his contributions through prestigious fellowships, including the National Science Foundation's Innovation Fellowship.

Areas of Expertise

Venture capital and investment analysis in life sciences and biotechnology

Computational biology and machine learning for drug discovery and biomedical applications

Startup leadership and product development in the AI and life sciences sectors

Collaborative research and cross-functional team management

Professional Impact

Developed groundbreaking deep learning models that accelerated small molecule drug discovery, leading to the successful acquisition of a startup

Provided strategic guidance and technical expertise to help drive the growth and expansion of Mubadala Capital's life sciences and biotech portfolio

Co-founded Lumos Bio, a promising startup that leverages AI and computational biology to develop innovative biotherapeutics

Conclusion

Arash Keshavarzi's multifaceted career, spanning venture capital, computational biology, and entrepreneurship, demonstrates his exceptional ability to bridge the gap between cutting-edge technology and real-world industry challenges. As he continues to push the boundaries of innovation, Arash is poised to make significant contributions to the advancement of life sciences and biotechnology.